tiprankstipranks
Trending News
More News >
Mitsui Chemicals Inc (JP:4183)
:4183

Mitsui Chemicals (4183) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4183

Mitsui Chemicals

(4183)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
¥4,097.00
▲(100.29% Upside)
Mitsui Chemicals' stock score is primarily influenced by its stable financial performance and technical indicators, which suggest a neutral to slightly bullish outlook. However, the high P/E ratio indicates overvaluation, which could limit growth potential. The attractive dividend yield provides some compensation for valuation concerns. The absence of earnings call and corporate events data means these factors did not influence the score.
Positive Factors
Business Model Strength
The focus on high-value-added products supports margin sustainability and competitive advantage, enhancing long-term profitability.
Market Position
Diverse sector operations provide resilience against market fluctuations, supporting stable revenue streams and long-term growth.
Balance Sheet Health
A balanced debt-to-equity ratio indicates financial stability, allowing for strategic investments and growth opportunities.
Negative Factors
Revenue Growth Trends
Declining revenue growth suggests potential market challenges, which could impact long-term expansion and market share.
Margin Sustainability
Decreasing net profit margins highlight challenges in maintaining profitability, potentially affecting long-term financial health.
Cash Generation Ability
Declining free cash flow growth limits the ability to fund future investments, impacting growth and strategic initiatives.

Mitsui Chemicals (4183) vs. iShares MSCI Japan ETF (EWJ)

Mitsui Chemicals Business Overview & Revenue Model

Company DescriptionMitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyMitsui Chemicals generates revenue through multiple streams, primarily from the sale of its chemical and polymer products to various industries. The company focuses on high-value-added products, which tend to offer better margins. Key revenue streams include functional chemicals, such as adhesives and coatings, performance materials like engineering plastics and films, and agricultural chemicals. Mitsui Chemicals also engages in strategic partnerships and joint ventures with other companies to enhance its market reach and develop new technologies. Additionally, the company invests in research and development to innovate and improve its product offerings, which contributes to its competitive advantage and overall earnings.

Mitsui Chemicals Financial Statement Overview

Summary
Mitsui Chemicals demonstrates a stable financial position with room for improvement in profitability and cash flow management. The income statement shows pressure on margins and revenue growth, while the balance sheet remains solid with moderate leverage. Cash flow analysis indicates challenges in generating free cash flow, necessitating strategic adjustments to enhance financial performance.
Income Statement
65
Positive
Mitsui Chemicals shows a mixed performance in its income statement. The TTM data indicates a slight decline in revenue growth at -2.40%, reflecting potential market challenges. However, the company maintains a stable gross profit margin of approximately 21.5%, suggesting efficient cost management. The net profit margin has decreased to 0.85%, indicating pressure on profitability. EBIT and EBITDA margins are relatively low at 2.96% and 8.65%, respectively, signaling room for operational improvements.
Balance Sheet
70
Positive
The balance sheet reveals a moderate financial structure with a debt-to-equity ratio of 0.90, indicating a balanced approach to leveraging. The return on equity (ROE) has decreased to 1.77%, which is a concern for shareholder returns. The equity ratio stands at a healthy level, suggesting a solid asset base. Overall, the balance sheet reflects stability but highlights the need for improved profitability.
Cash Flow
60
Neutral
Cash flow analysis shows a decline in free cash flow growth at -7.56%, which could impact future investments. The operating cash flow to net income ratio is 0.34, indicating adequate cash generation relative to net income. However, the free cash flow to net income ratio is 0.43, suggesting limited cash available after capital expenditures. The cash flow statement highlights the need for better cash management strategies.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.73T1.81T1.75T1.88T1.61T1.21T
Gross Profit377.26B388.29B370.80B381.49B378.74B293.84B
EBITDA152.62B186.12B183.24B197.27B204.58B150.44B
Net Income17.86B32.24B50.00B82.94B109.99B57.87B
Balance Sheet
Total Assets2.10T2.15T2.22T2.07T1.93T1.56T
Cash, Cash Equivalents and Short-Term Investments198.75B209.23B210.29B186.31B181.15B195.99B
Total Debt696.42B737.98B756.76B738.25B666.09B510.22B
Total Liabilities1.12T1.18T1.23T1.18T1.13T875.97B
Stockholders Equity854.37B848.28B862.85B786.83B712.65B607.92B
Cash Flow
Free Cash Flow82.72B62.09B7.35B-36.62B-23.63B97.74B
Operating Cash Flow209.74B200.50B161.34B101.24B92.58B174.32B
Investing Cash Flow-176.71B-165.01B-123.94B-106.34B-205.23B-77.56B
Financing Cash Flow-40.38B-74.44B-26.02B2.54B89.22B-68.96B

Mitsui Chemicals Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2045.50
Price Trends
50DMA
1924.50
Positive
100DMA
1880.75
Positive
200DMA
1738.35
Positive
Market Momentum
MACD
38.68
Negative
RSI
68.40
Neutral
STOCH
64.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4183, the sentiment is Positive. The current price of 2045.5 is above the 20-day moving average (MA) of 2002.60, above the 50-day MA of 1924.50, and above the 200-day MA of 1738.35, indicating a bullish trend. The MACD of 38.68 indicates Negative momentum. The RSI at 68.40 is Neutral, neither overbought nor oversold. The STOCH value of 64.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4183.

Mitsui Chemicals Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥389.53B10.829.34%4.27%-0.48%-35.29%
75
Outperform
¥718.20B20.4112.15%1.58%2.62%2.81%
74
Outperform
¥293.05B11.115.47%3.41%2.60%9.50%
67
Neutral
¥1.15T22.163.63%3.98%-1.17%
64
Neutral
¥814.41B44.062.02%3.82%-4.63%-65.11%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
¥589.16B-79.88-1.15%3.49%-6.83%-123.67%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4183
Mitsui Chemicals
2,083.00
517.76
33.08%
JP:5201
AGC
5,412.00
1,184.70
28.03%
JP:4202
Daicel
1,466.00
204.81
16.24%
JP:4118
Kaneka
4,634.00
1,164.74
33.57%
JP:4182
Mitsubishi Gas Chemical Company
3,037.00
411.66
15.68%
JP:4403
NOF
3,042.00
1,002.84
49.18%

Mitsui Chemicals Corporate Events

Mitsui Chemicals Announces Stock Split and Dividend Revision
Nov 11, 2025

Mitsui Chemicals, Inc. announced a two-for-one stock split to make its shares more affordable and expand its investor base. The company also revised its dividend forecast in line with the stock split, although there is no effective change from the previous forecast, indicating a strategic move to maintain shareholder value.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen3812.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports Decline in First Half FY2025 Financial Results
Nov 11, 2025

Mitsui Chemicals reported a decline in sales revenue and operating income for the first half of FY2025 compared to the previous year. The company has undergone organizational reforms and segment revisions, impacting its financial performance. Despite the challenges, certain segments like ICT solutions showed growth, while others like basic & green materials experienced significant declines. The company also announced a two-for-one stock split, affecting dividend forecasts.

The most recent analyst rating on (JP:4183) stock is a Hold with a Yen3812.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025